Авторы трудов (статей) использованные при подготовке материалов по химическому пилингу
В ходе подготовки статей по химическому пилингу для пользователей сайта МедУнивер использованы труды следующих авторов:
Grimes РЕ, Rendon М, Pallerano J (2008) Superfi cial chemical peels in aesthetics & cosmetic surgery in darker skin types. Lippincott Williams & Wilkins, Philadelphia, pp 155-169
Swinehart JM (1992) Salicylic acid ointment peeling of the hands and forearms. Effective nonsurgical removal of pigmented lesions and actinic damage. J Dermatol Surg Oncol 18(6):495-498
Lazo ND, Meine JG, Downing DT (1995) Lipids are covalently attached to rigid comeocyte protein envelope existing predominantly as beta-sheets: a solid state nuclear magnetic resonance study. J Invest Dermatol 105:296-300
Imayama S, Ueda S, Isoda M (2000) Histologic changes in the skin of hairless mice following peeling with salicylic acid. Arch Dermatol 136:1390-1395
Matarasso SL, Glogau RG (1991) Chemical face peels. Dermatol Clin 9:131-150
Rajalingam D, Loftis C, Xu JJ, Kumar TK (2009) Trichloroacetic acid induced protein precipitation involves the reversible association of a stable partially structured intermediate. Protein Sci 18:980-993
Bridenstine JB, Dolezal JF (1994) Standardizing chemical peel solution formulations to avoid mishaps. Great fluctuations in actual concentrations of trichloroacetic acid. J Dermatol Surg Oncol 20(12):813-816
Hexsel D, Mazzuco R, Dal’Fomo T, Zechmeis-ter D (2005) Microdermabrasion followed by a 5% retinoid acid peel vs. a 5% retinoid acid peel for the treatment of photoaging - a pilot study. J Cosmet Dermatol 4:111-116
Kisner AM (2001) Microdermabrasion with chemical peel. Aesthet Surg J 21 (2): 191—193
Briden E, Jacobsen E, Johnson C (2007) Combining superficial glycolic acid (alpha-hydroxy acid) peels with microdermabrasion to maximize treatment results and patient satisfaction. Cutis 79(1 Suppl Combining): 13-16
Cotellessa C, Peris K, Fargnoli MC, Mordenti C, Giacomello RS, Chimenti S (2003) Microabrasion versus microabrasion followed by 15% trichloroacetic acid for treatment of cutaneous hyperpigmentations in adult females. Dermatol Surg 29(4):352-356
Zakopoulou N, Kontochristopoulos G (2006) Superficial chemical peels. J Cosmet Dermatol 5:246-253
AlKhawam L, Alam M (2009) Dermabrasion and microdermabrasion. Facial Plast Surg 25(5):301-310
Song JY, Kang HA, Kim M-Y et al (2004) Damage and recovery of skin barrier function after glycolic acid chemical peeling and crystal microdermabrasion. Dermatol Surg 30:390-394
Farris P, Rietschel R (2002) An unusual acute urticarial response following microdermabrasion. Dermatol Surg 28:606-608
Liebl Н (2009) Abstract refl ections about Collagen-Induction-Therapy (CIT). A hypothesis for the mechanism of action of collagen induction therapy (cit) using microneedles. January 2-7. www.dermaroller.de/us/sci-ence/abstractreflections-26.html. Feb Accessed 15 Apr 2009
Jacob CI, Dover JS, Kaminer MS (2001) Acne scarring: a classifi cation system and review of treatment options. J Am Acad Dermatol 45:105-117
Goodman GJ, Baron JA (2006) Postacne scarring: a qualitative global scarring grading system. Dermatol Surg 32:1458-1466
Church S. Skin Needling - Natural Collagen Renewal. International Institute of Permanent Cosmetics. Internet paper. spmuc.com.au/downloads/Skin-Needling-What.pdf
Chu ТС (1997) Acne and other facial eruptions. Medicine 25:30-33
Simpson NB, Cunliffe WJ (2004) Disorders of sebaceous glands. In: Bums T, Breathnach S, Cox N, Griffi ths C (eds) Rook’s textbook of dermatology, 7th edn. Blackwell Publishing, Oxford, pp 43.1 -43.75
Simpson NB (1992) Acne and the mature female. Science Press, London
Goulden V, Stables GI, Cunliffe WJ (1999) Prevalence of facial acne in adults. J Am Acad Dermatol 41:577-580
White GM (1998) Recent fl ndings in the epidemiologic evidence, classifi cation, and subtypes of acne vulgaris. J Am Acad Dermatol 39:S34—S37
Jeremy AHT, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ (2003) Infl ammatory events are involved in acne lesion initiation. J Invest Dermatol 121:20-27. (ncbi.nlm.nih.gov/pubmed/12839559)
Doshi A, Zaheer A, Stiller MJ (1997) A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol 38:416-418
Jacob CI, Dover JS, Kaminer MS (2001) Acne scarring: a classifi cation system and review of treatment options. J Am Acad Dermatol 45:105-117
Goodman GJ, Baron JA (2006) Postacne scarring: a qualitative global scarring grading system. Dermatol Surg 32:1458-1466
Layton AM, Henderson CA, Cunliffe WJ (1994) A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 19:303-308
Katsambas AD, Katoulis AC, Stavropoulos P (1999) Acne neonatorum: a study of 22 cases. Int J Dermatol 38(2): 128—130
Thielitz A, Gollnick H (2008) Topical retinoids in acne vulgaris: update on effi cacy and safety. Am J Clin Dermatol 9(6):369—381
Adisen E, Kaymak Y, Gurer MA, Durukan E (2008) Topical tetracycline in the treatment of acne vulgaris. J Drugs Dermatol 7(10):953-955
Fabbrocini G, Cacciapuoti S, Fardella N, Pastore F, Monfrecola G (2008) Cross technique: chemical reconstruction of skin scars method. Dermatol Ther 21 :S29-S32
Holian O, Walter RJ (2001) Resveratrol inhibits the proliferation of normal human keratinocytes in vitro. J Cell Biochem Suppl. (Suppl 36): 55-62
Docherty JJ et al (2007) Resveratrol inhibition of Propionibacterium acnes . J Antimicrob Chemother 59(6): 1182-1184, Epub Apr 21, 2007. (http://jac.oxfordjournals.org/content/59/6Z H82.full)
Gao X et al (2003) Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. Biochem Pharmacol 66(12):2427-2435
Fabbrocini G, Staibano S, De Rosa G, Battimiello V, Fardella N, Ilardi G, La Rotonda MI, Longobardi A, Mazzella M, Siano M, Pastore F, De Vita V,Vecchione ML, Ayala F (2011) Resveratrol-Containing Gel for the Treatment of Acne Vulgaris: A Single-Blind, Vehicle-Controlled, Pilot Study. Am J Clin Dermatol 12(2): 133-141
Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM (1993) Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 306:555-556
Thiim M, Friedman LS (2003) Hepatotoxicity of antibiotics and antifungals. Clin Liver Dis 7:381-399
Wang HS, Wang TH, Soong YK (1999) Low dose flutamide in the treatment of acne vulgaris in women with or without oligomenorrhea or amenorrhea. Changgeng Yi Xue Za Zhi 22:423-432
Wolff H (1999) Finasteride: also effective in acne vulgaris? Hautarzt 50:815
Monheit GD (1989) Jessner’s + TCA peel: a medium depth chemical peel. J Dermatol Surg Oncol 15:945-950
Huber C, Christophers E (1977) Keratolytic effect of salicylic acid. Arch Dermatol Res 257:293-297
Lazo ND, Meine JG, Downing DT (1995) Lipids are covalently attached to rigid comeocyte protein envelope existing predominantly as beta-sheets: a solid state nuclear magnetic resonance study. J Invest Dermatol 105:296-300
Rook A, Wilkinson DS, Ebling FJG (1972) Textbook of dermatology. Blackwell Scientific, Oxford, pp 2072-2075
Van Scott EJ, Yu RJ (1984) Hyperkeratiniza-tion, comeocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol 11(5 Pt l):867-879
Safoury OS, Zaki NM, El Nabarawy EA, Farag EA (2009) A study comparing chemical peeling using modifi ed Jessner’s solution and 15% trichloroacetic acid versus 15% trichloroacetic acid in the treatment of melasma. Indian J Dermatol 54( 1):41 45
Bagatin E, Teixeira SP, Hassun KM, Pereira T, Michalany NS, Talarico S (2009) 5-Fluorouracil superfi cial peel for multiple actinic keratoses. Int J Dermatol 48(8):902-907
Ejaz A et al (2008) Comparison of 30% salicylic acid with Jessner’s solution for superficial chemical peeling in epidermal melasma. J Coll Physicians Surg Pak 18:205-208
Kadhim KA, Al-Waiz M (2005) Treatment of periorbital wrinkles by repeated medium-depth chemical peels in darkskinned individuals. J Cosmet Dermatol 4(1): 18-22
Matarasso SL, Glogau RG (1991) Chemical face peels. Dermatol Clin 9:131-150
Rubin MG (1995) Manual of chemical peels: superficial and medium depth. J.B. Lippincott Company, Philadelphia, pp 79-88
Brody HJ (1997) Chemical peeling and resurfacing, 2nd edn. Mosby, St. Louis
Lynch BS, Delzell ES, Bechtel DH (2002) Toxicology review and risk assessment of resorcinol: thyroid effects. Regul Toxicol Pharmacol 36:198-210
Barbaud A, Modiano P, Cocciale M et al (1996) The topical application of resorcinol can provoke a systemic allergic reaction. Br J Dermatol 135:1014-1015
Baskettter DA, Sanders D, Jowsey IR (2007) The skin sensitization potential of resorcinol: experience with the local lymph node assay. Contact Dermatitis 56(4): 196-200
Thomas AE, Gisbum MA (1961) Exogenous ochronosis and myxoedema from resorcinol. Br J Dermatol 73:378-381
Маскее GM, Karp FL (1952) The treatment of post acne scars with phenol. Br J Dermatol 64:456-459
Bames HO (1927) Truth and fallacies of face peeling and face lifting. Med J Rec 126:86-87
Urkov JC (1946) Surface defects of the skin: treatment by controlled exfoliation. Ill Med J 89:75
Combes FC, Sperber PA, Reisch M (1960) Dermal defects: treatment by a chemical agent. NY Physician Am Med 56:36
Brown AM, Kaplan LM, Brown ME (1960) Phenol induced histological skin changes: hazards, techniques and users. Br J Plast Surg 13:158
Litton C (1962) Chemical face lifting. Plast Reconstr Surg 29:371
Baker TJ (1962) Chemical face peeling and rhytidectomy. Plast Reconstr Surg 29:199
Baker TJ, Gordon HL (1961) The ablation of rhytids by chemical means: a preliminary report. J Fla Med Assoc 48:541
Stone PA, Lefer LG (2001) Modifi ed phenol chemical face peels: recognizing the role of application technique. Clin Plast Surg 9:351-376
Spira M, Dahl C, Freeman R et al (1970) Chemosurgery: a histological study. Plast Reconstr Surg 45:247
Hetter G (2000) An examination of the phenol-croton oil peel: part I. Dissecting the formula. Plast Reconstr Surg 105:239-248
Fintsi Y (1997) Exoderm- a novel phenol-based peeling method resulting in improved safety. Am J Cosmet Surg 14:49-54
Larson DL, Karmo F, Hetter GP(2009) Phenol-croton oil peel: establishing an animal model for scientifi c investigation. Aesthet Surg J 29:47-53
Baker TJ, Gordon HL, Seckinger DL (1966) A second look at chemical face peeling. Plast Reconstr Surg 37:487
Baker TJ, Gordon HL, Mosienko P et al (1974) Long-term histological study of skin after chemical face peeling. Plast Reconstr Surg 53:522
Fintsi Y, Landau M (2001) Exoderm: phenol-based peeling in olive and dark skinned patients. Int J Cosmet Surg Aesthet Dermatol 3:173—178
Park JH, Choi YD, Kim SW, Kim YC, Park SW (2007) Effectiveness of modifi ed phenol peel (Exoderm) on facial wrinkles, acne scars and other skin problems of Asian patients. J Dermatol 34:17-24
Gatti JE (2008) Eyelid phenol peel: an important adjunct to blepharoplasty. Ann Plast Surg 60:14-18
Litton C, Trinidad G (1981) Complications of chemical face peeling as evaluated by a questionnaire. Plast Reconstr Surg 67:738-744
Wexler MR, Halon DA, Teitelbaum A et al (1984) The prevention of cardiac arrhythmias produced in an animal model by topical application of a phenol preparation in common use for face peeling. Plast Reconstr Surg 73:595-598
Truppman F, Ellenbery J (1979) The major electrocardiographic changes changes during chemical face peeling. Plast Reconstr Surg 63:44
Landau M (2007) Cardiac complications in deep chemical peels. Dermatol Surg 33:190-193
Gleason MD, Gosselin RF, Hodge HC et al (1969) Clinical toxicology of commercial products. Williams & Williams, Baltimore, pp 189-192
Brody HJ (1997) Chemical peeling and resurfacing, 2nd edn. Mosby, pp 188-189
Brody HJ (1997) Chemical peeling and resurfacing, 2nd edn. Mosby, pp 168-178
Van Scott EJ, Yu RJ (1974) Control of keratinization with alpha-hydroxy acids and related compounds. 1. Topical treatment of ichthyotic disorders. Arch Dermatol 110:586-590
Kataoka M, Sasaki M, Hidalgo AR, Nakano M, Shimizu S (2001) Glycolic acid production using ethylene glycol-oxidizing microorganism. Biosci Biotechnol Biochem 65(10):2265-2270
Bernstein EF, Lee J, Brown DB, Yu R, Van Scott E (2001) Glycolic acid treatment increases type I collagen mRNA and hyaluronic acid content of human skin. Dermatol Surg 27(5): 429-433
Becker FF, Langford FP, Rubin MG, Speelman P (1996) A histological comparison of 50% and 70% glycolic acid peels using solutions with various pHs. Dermatol Surg 22(5):463-465
Moy LS, Murad H, Moy RL (1993) Glycolic acid peels for the treatment of wrinkles and photoaging. J Dermatol Surg Oncol 19(3):243-246
Fuchs KO, Solis O, Tapawan R, Paranjpe J (2003) The effects of an estrogen and glycolic acid cream on the facial skin of postmenopausal women: a randomized histologic study. Cutis 71(6):481-488
Kim SW, Moon SE, Kim JA, Eun HC (1999) Glycolic acid versus Jessner’s solution: which is better for facial acne patients? A randomised prospective clinical trial of splitface model therapy. Dermatol Surg 25(4):270-273
Murad H, Shamban AT, Premo PS (1995) The use of glycolic acid as a peeling agent. Dermatol Clin 13(2):285-307
Gladstone HB, Nguyen SL, Williams R, Ot-tomeyer T, Wortzman M, Jeffers M, Moy RL (2000) Efficacy of hydroquinone cream (USP 4%) used alone or in combination with salicylic acid peels in improving photodamage on the neck and upper chest. Dermatol Surg 26(4):333-337
Koppel RA, Coleman KM, Coleman WP(2000) The efficacy of ELMA versus ELA-Max for pain relief in mediumdepth chemical peeling: a clinical and histopathologic evaluation. Dermatol Surg 26(l):61-64
Javaheri SM, Handa S, Kaur I, Kumar В (2001) Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol 40(5):354-357
Atzori L, Brundu МА, Orru A, Biggio Р(1999) Glycolic acid peeling in the treatment of acne. J Eur Acad Dermatol Venereol 12(2): 119-122
Erbagci Z, Akcali C (2000) Biweekly serial glycolic acid peels vs. long-term daily use of topical lowstrength glycolic acid in the treatment of atrophic acne scars. Int J Dermatol 39(10):789-794
Ash K, Lord J, Zukowski M, McDaniel DH (1998) Comparison of topical therapy for striae alba (20% glycolic acid/ 0,05% tretinoin versus 20% glycolic acid/ 10% L-ascorbic acid). Dermatol Surg 24(8):849-856
Perricone NV (1993) Treatment of pseudofolliculitis barbae with topical glycolic acid: a report of two studies. Cutis 52(4):232-235
Kostarelos K, Teknetzis A, Lefaki I, loannides D, Minas A (2000) Double-blind clinical study reveals synergistic action between alpha-hydroxy acid and betamethasone lotions towards topical treatment of scalp psoriasis. J Eur Acad Dermatol Venereol 14( 1):5—9
Tung RC, Bergfeld WF, Vidimos AT, Remzi BK (2000) Alpha-hydroxy acid-based cosmetic procedures. Guidelines for patient management. Am J Clin Dermatol 1(2):81-88
Zhai H, Hannon W, Hahn GS, Pelosi A, Harper RA, Maibach HI (2000) Strontium nitrate suppresses chemically induced sensory irritation in humans. Contact Dermat 42(2):98-100
Parks KS, Kim HJ, Kim EJ, Nam KT, Oh JH, Song CW, Jung HK, Kim DJ, Yun YW, Kim HS, Chung SY, Cho DH, Kim BY, Hong JT (2002) Effects of glycolic acid on UVBinduced skin damage and infl ammation in guinea pigs. Skin Pharmacol Appl Skin Physiol I5(4):236-245
Lazo ND, Meine JG, Downing DT (1995) Lipids are covalently attached to rigid corneocyte protein envelope existing predominantly as beta-sheets: a solid state nuclear magnetic resonance study. J Invest Dermatol 105:296-300
Swinehart JM (1992) Salicylic acid ointment peeling of the hands and forearms. Effective nonsurgical removal of pigmented lesions and actinic damage. J Dermatol Surg Oncol 18:495-498
Aronsohn RB (1984) Hand chemosurgery. Am J Cosmet Surg 1:24-28
Kligman D, Kligman AM (1998) Salicylic acid peels for the treatment of photoaging. Dermatol Surg 24:325-328
Imayama S, Ueda S, Isoda M (2000) Histologic changes in the skin of hairless mice following peeling with salicylic acid. Arch Dermatol 136:1390-1395
Draelos ZD (2000) Atlas of cosmetic dermatology. Churchill Livingstone, New York, pp 94-97
Grimes PE (1999) The safety and effi cacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 25:18-22
Lee HS, Kim IH (2003) Salicylic acid peels for the treatment of acne vulgaris in Asian patients. Dermatol Surg 29:1196-1199
Joshi SS, Boone SL, Alam M et al (2009) Effictiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinfl ammatory hyperpigmentation in dark skin. Dermatol Surg 35:638-644
Ahn HH, Kim IH (2006) Whitening effect of salicylic acid peels in Asian patients. Dermatol Surg 32:372-375
Kodali S (2010) A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women. J Am Acad Dermatol 63:1030-1035
Oresajo C, Yatskayer M, Hansenne I (2008) Clinical tolerance and effi cacy of capryloyl salicylic acid peel compared to a glycolic acid peel in subjects with fine lines/wrinkles and hyperpigmented skin. J Cosmet Dermatol 7:259-262
Brody HJ (1997) Chemical peeling, 2nd edn. Mosby, St Louis
Bhawan J, Olsen E, Lufrano L, Thome EG, Schwab B, Gilchrest BA (1996) Histologic evaluation of the long term effects of tretinoin on photodamaged skin. J Dermatol Sci 11:177-182
Jimbow K, Obata H, Pathak MA et al (1974) Mechanism of depigmentation by hydroquinone. J Invest Dermatol 62:436—449
Berardesca Е, Cameli N, Primavera G et al (2006) Clinical and instrumental evaluation of skin improvement after treatment with a new 50% pyruvic acid peel. Dermatol Surg 32(4):526-531
Cotellessa C, Manunta T, Ghersetich I, Brazzini B, Lotti T, Peris К (2004) The use of pyruvic acid in the treatment of acne. J Eur Acad Dermatol Venereol 18(3):275-278
Fabbrocini G, De Padova MP, Tosti A (2009) Chemical peels: what’s new and what isn’t new but still works well. Facial Plast Surg 25(5):329-336
Ghersetich I, Brazzini B, Lotti T (2003) Chemical peeling. In: Lotti TM, Katsambas AD (eds) European handbook of dermatological treatments, 2nd edn. Sprinter, Berlin/Heidelberg
Ghersetich I, Brazzini B, Peris K, Cotellessa C, Manunta T, Lotti T (2004) Pyruvic acid peels for the treatment of photoaging. Dermatol Surg 30(l):32-36
Griffin TD, Van Scott EJ (1991) Use of pyruvic acid in the treatment of actinic keratoses: a clinical and histopathologic study. Cutis 47:325-329
Griffin TD, Van Scott EJ, Maddin S (1989) The use of pyruvic acid as a chemical peeling agent. J Dermatol Surg Oncol 15:1316
Halasz CL (1998a) Treatment of warts with topical pyruvic acid: with and without added 5-fluoroura-cil. Cutis 62(6):283-285
Halasz CL (1998b) Treatment of warts with topical pyruvic acid with and without added 5-fluoroura-cil. Cutis 62:283-285
Moy LS, Peace S, Moy RL (1996) Comparison of the effect of various chemical peeling agents in a mini pig model. Dermatol Surg 22:429-432
Seitz JC, Whitemore CG (1988) Measurement of erythema and tanning response in human skin using a Tri-Stimulus colorimeter. Dermatologica 177:70-75
Tosson Z, Attwa E, Al-Mokadem S (2006) A pyruvic acid as a new therapeutic peeling agent in acne, melasma, and warts. EDOJ 2(2):7. edoj.org.eg/vol002/00202/07/01.htm
Brody HJ (2001) Complications of chemical resurfacing. Dermatol Clin 3:427-437
Koppel RA, Coleman KM, Coleman WP (2000) The effi cacy of EMLA versus ELA-Max for pain relief in medium-depth chemical peeling: a clinical and histopathologic evaluation. Dermatol Surg 26:61-64
Monheit GD (1996) Skin preparation: an essential step before chemical peeling or laser resurfacing. Cosmet Dermatol 9:9-14
Monheit GD (2001) Medium-depth chemical peels. Dermatol Clin 3:413-525
Rubin MG (1995) Manual of chemical peel: superficial and medium depth. Lippincott, Philadelphia
Bhawan J, Andersen W, Lee J, Labadie R, Solares G (1995) Photoaging versus intrinsic aging: a morphologic assessment of facial skin. J Cutan Pathol 22(2): 154-159
Gilchrest BA (1996) A review of skin aging and its medical therapy. Br JDermatol 135:867-875
Lavker RM (1995) Cutaneous aging: chronologic versus photoaging. In: Gilchrest BA (ed) Photodamage. Blackwell Science, Cambridge, pp 123-135
Vayalil PK, Mittal A, Hara Y, Elmets CA, Kati-yar SK (2004) Green tea polyphenols prevent ultraviolet light-induced oxidative damage and matrix metalloproteinases expression in mouse skin. J Invest Dermatol 122(6): 1480-1487
Kaczvinsky JR Jr, Grimes PE (2009) Practical applications of genomics research for treatment of aging skin. J Drugs Dermatol 8(7 Suppl):s15-s18
Spencer JM (2004) Premalignant manifestations of photoaging: actinic keratoses and atypical nevi. In: Goldberg DJ (ed) Photodamaged skin. Marcel Dekker, Inc, New York, pp 1-16
Grimes PE (2004) Benign manifestations of photodamage: ethnic skin types. In: Goldberg DJ (ed) Photodamaged skin. Marcel Dekker, Inc, New York, pp 175-196
Washington CV, Grimes PE (2003) Incidence and prevention of skin cancer. Cosmet Dermatol 16(S3):46-48
Glogau RG (1994) Chemical peeling and aging skin. J Geriatr Dermatol 2:30-35
Fulton JE, Porumb S (2004) Chemical peels: their place within the range of resurfacing techniques. Am J Clin Dermatol 5(3): 179-187
Seite S, Colige A, Piquemal-Vivenot P, Montastier C, Fourtanier A, Lapiere C, Nusgens В (2000) A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging. Photodermatol Photoimmunol Photomed 16(4): 147-155
Kang S, Leyden JJ, Lowe NJ et al (2001) Tazarotene cream for the treatment of facial photodamage. Arch Dermatol 137:1597-1604
Chandraratna RAS (1996) Tazarotene: first of a new generation of receptor-selective retinoids. Br J Dermatol 135:18-25
Weinstein GD, Nigra TP, Pochi PE et al (1991) Topical tretinoin for treatment of photodamaged skin: a multicenter study. Arch Dermatol 127:659-665
Levin A A, Sturzenbecker LJ, Kazmer S et al (1992) 9-cis Retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature 355:359-361
Griffiths CEM, Goldfarb MT, Finkel LJ et al (1994) Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: a vehicle-controlled trial. J Am Acad Dermatol 30:76-84
Tadaki T, Watanabe M, Kumasaka K, Tanita Y, Kato T, Tagami H, Horii 1, Yokoi T, Nakayama Y, Kligman AM (1993) The effect of topical tretinoin on the photodamaged skin of the Japanese. Tohoku J Exp Med 169(2): 131-139
Griffi ths CE, Kang S, Ellis CN, Kim KJ, Finkel LJ, Ortiz-Ferrer LC, White GM, Hamilton TA, Voorhees JJ (1995) Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams. Arch Dermatol 131 (9): 1037-1044
Griffi ths CE, Russman AN, Majmudar G, Singer RS, Hamilton TA, Voorhees JJ (1993) Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 329(8):530-535
Weiss JS, Shavin JS, Nighland M, Grossman R (2006) Tretinoin microsphere gel 0.1% for photodamaged facial skin: a placebo-controlled trial. Cutis 78(6):426-432
Kang S, Bergfeld W, Gottlieb AB, Hickman J, Humeniuk J, Kempers S, Lebwohl M, Lowe N, McMichael A, Milbauer J, Phillips T, Powers J, Rodriguez D, Savin R, Shavin J, Sherer D, Silvis N, Weinstein R, Weiss J, Hammerberg C, Fisher GJ, Nighland M, Grossman R, Nyirady J (2005) Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial. Am J Clin Dermatol 6(4):245-253
Fleischer AB, Schwartzel EH, Colby SI, Altman DJ, the Depigmenting Solution Study Group (2000) The combination of 2% 4-hy-droxyanisole (mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies. J Am Acad Dermatol 42:459-467
Jarrett M (2004) Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. Cutis 74:310-322
Draelos ZD (2006) The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups. J Cosmet Dermatol 5:239-244
Kang S, Krueger GG, Tanghetti EA et al (2005) A multicenter, randomized, double-blind trial of tazarotene 0.1 % cream in the treatment of photodamage. J Am Acad Dermatol 52:268—274
Sefton J, Kligman AM, Kopper SC, Lue JC, Gibson JR (2000) Photodamage pilot study: a double-blind, vehiclecontrolled study to assess the effi cacy and safety of tazarotene 0.1% gel. J Am Acad Dermatol 43:656-663
Cosmetic Ingredient Review (1987) Final report on the safety assessment of retinyl palmitate and retinol. J Am Coll Toxicol 6:279-320
Suzuki S, Miyachi Y, Niwa Y, Isshiki N (1989) Signifi cance of reactive oxygen species in distal flap necrosis and its salvage with liposomal SOD. Br J Plast Surg 42:559-564
Kang S, Duell EA, Fisher GJ et al (1995) Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol 105:549-556
Tucker-Samaras S, Zedayko T, Cole C, Miller D, Wallo W, Leyden JJ (2009) A stabilized 0.1% retinol facial moisturizer improves the appearance of photodamaged skin in an eight-week, double-blind, vehicle-controlled study. J Drugs Dermatol 8(10):932-936
Kikuchi K, Suetake T, Kumasaka N, Tagami H (2009) Improvement of photoaged facial skin in middle-aged Japanese females by topical retinol (vitamin A alcohol): a vehicle-controlled, double-blind study. J Dermatolog Treat 20(5):276-281
Jimbow K, Obata H, Pathak MA et al (1974) Mechanism of depigmentation by hydroquinone. J Invest Dermatol 62:436-449
AmerM, Metwalli M (1998) Topical hydroquinone in the treatment of some hyperpigmentary disorders. Int J Dermatol 37:449-450
Embil K, Nacht S (1996) The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul 13:575-588
Grimes PE (2004) A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinfl ammatory hyperpigmentation. Cutis 74:362-368
Cook-Bolden FE, Hamilton SF (2008) An openlabel study of the effi cacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.1 5% with antioxidants for the treatment of hyperpigmentation. Cutis 81:365-371
Mahe A, Ly F, Aymard G, Dangou JM (2003) Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br J Dermatol 148(3)493-500
Bellew SG, Alster TS (2004) Treatment of exogenous ochronosis with a Q-switched alexandrite (755 nm) laser. Dermatol Surg 30(4 Pt 1): 555-558
Fitton A, Goa KL (1991) Azelaic acid. Drugs 41:780-798
Nakagawa M, Kawai K, Kawai К (1995) Contact allergy to kojic acid in skin care products. Contact Dermat 32:9-13
Mata TL, Sanchez JP, De La Cuadra Oyan-guren J (2005) Allergic contact dermatitis due to kojic acid. Dermatitis 16:89
Garcia-Gavin J, Gonzalez-Vilas D, Fernandez-Redondo V, Toribio J (2010) Pigmented contact dermatitis due to kojic acid. A paradoxical effect of a skin lightener. Contact Dermat 62:63-64
Bissett DL, Chatterjee R, Hannon DP (1990) Photoprotective effect of superoxide-scavenging antioxidants against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatol Photoimmunol Photomed 7:56-62
Darr D, Combs S, Dunston S, Manning T, Pin-nel S (1992) Topical vitamin C protects porcine skin from ultraviolet radiation-induced damage. Br J Dermatol 127:247-253
Black HS (1987) Potential involvement of free radical reactions in ultraviolet light mediated cutaneous damage. Photochem Photobiol 46:213-221
Eberlein-Konig B, Placzek M, Pryzbilla В (1998) Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J Am Acad Dermatol 38:45-48
Colvin RM, Pinnell SR (1996) Topical vitamin C in aging. Clin Dermatol 14:227-234
Bachowski GJ, Girotti AW (1988) Light-stimulated formation of hydrogen peroxide and hydroxyl radical in the presence of uroporphyrin and ascorbate. Free Radic Biol Med 5:3-6
Bacq ZM, Fischer P (1957) The action of various drugs on the suprarenal response of the rat to total-body x-irradiation. Radiat Res 7:365-372
Frei B, England L, Amos В (1989) Ascorbate is an outstanding anti-oxidant in human blood plasma. Proc Natl Acad Sci USA 86:6377-6381
Koch CJ, Biaglow JE (1978) Toxicity, radiation sensitivity modifi cation, and metabolic effects of dehydroascorbate and ascorbate in mammalian cells. J Cell Physiol 94:299-306
Bartlett MK, Jones CM, Ryan AE (1942) Vitamin C and wound healing: II. Ascorbic acid content and tensile strength of healing wounds in human beings. N Engl J Med 226:474 481
Padh H (1990) Cellular functions of ascorbic acid. Biochem Cell Biol 68:1166-1173
Abt AF, von Schurching S (1961) Catabolism of L-ascorbic-l-C acid as a measure of its utilization in the intact and wounded guinea pig on scorbutic maintenance, and saturation diets. Ann NY Acad Sci 92:148-158
Fitzpatrick RE, Rostan EF (2002) Double blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg 28:231-236
Humbert PG, Haftek M, Creidi P, Lapiere C, Nusgens B, Richard A, Schmitt D, Rougier A, Zahouani H (2003) Topical ascorbic acid on photoaged skin, clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo. Exp Dermatol 12(3):237-244
Perricone NV (1993) The photoprotective and anti-inflamatory effects of topical ascorbyl palmitate. J Geriatr Dermatol 1:5-10
Moy LS, Murad H, Moy RL (1993) Glycolic acid peels for the treatment of wrinkles and photoaging. J Dermatol Surg Oncol 19:243-246
Murad H, Shamban AT, Moy RL (1995) The use of glycolic acid as a peeling agent. Dermatol Clin 13:285-3074
Bernstein EF, Lee J, Brown DB, Yu R, Van Scott E (2001) Glycolic acid treatment increases type I collagen mRNA and hyaluronic acid content of human skin. Dermatol Surg 27(5):429-433
Okano Y, Abe Y, Masaki H, Santhanam U, Ichihashi M, Funasaka Y (2003) Biological effects of glycolic acid on dermal matrix metabolism mediated by dermal fi broblasts and epidermal keratinocytes. Exp Dermatol 12(Suppl 2):57-63
Ditre CM, Griffi n TD, Murphy GF, Sueki H, Telegan B, Johnson WC, Yu RJ, Van Scott EJ (1996) Effects of alphahydroxy acids on photoaged skin: a pilot clinical, histologic, and ultrastructural study. J Am Acad Dermatol 34 (2 Pt 1): 187-195
Grimes PE, Green BA, Wildnauer RH, Edison BL (2004) The use of polyhydroxy acids (PHAs) in photoaged skin. Cutis 73(2 Suppl):3-13
Zhu W, Gap J (2008) The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Investig Dermatol Symp Proc 13:20-24
Chang T-S (2009) An updated review of tyrosinase inhibitors. Int J Mol Sci 10:2440-2475
Smit N, Vicanova J, Pavel S (2009) The hunt for natural skin whitening agents. Int J Mol Sci 10:5326-5349
Bae JY, Choi JS, Kang SW, Lee YJ, Park J, Kang YH (2010) Dietary compound ellagic acid alleviates skin wrinkle and infl ammation induced by UV-B irradiation. Exp Dermatol 19(8):el82-el90
Ertam I, Mutlu B, Unal I, Alper S, Kivfak B, Ozer О (2008) Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open-label study. J Dermatol 35:570-574
Wallo W, Neybus J, Leyden JJ (2007) Efficacy of a soy moisturizer in photoaging: a doubleblind, vehicle-controlled, 12-week study. J Drugs Dermatol 6:917-922
Bissett DL, Oblong JE, Berge CA (2005) Niacinamide: A В vitamin that improves aging facial skin appearance. Dermatol Surg 31(7 Pt 2):860-865, discussion 865
Kawada A, Konishi N, Oiso N, Kawara S, Date A et al (2008) Evaluation of anti-wrinkle effects of a novel cosmetic containing niacinamide. J Dermatol 35(10):637-642
Katoulis AC, Alevizou A, Bozi E, Makris M, Zafeiraki A, Mantas N, Kousta F, Mistidou M, Kanelleas A, Stavrianeas NG (2010) A randomized, double-blind, vehicle controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines. Clin Exp Dermatol 35(5):473-6
Calzavara-Pinton P, Zane C, Facchinetti E, Capezzera R, Pedretti A (2010) Topical Boswellic acids for treatment of photoaged skin. Dermatol Ther23(Suppl 1):S28-S32
Ghersetich I, Troinano M, De Girogi V, Lotti T (2007) Receptors in skin ageing and antiageing agents. Dermatol Clin 25(4):655-662, xi. Review
Stegman SJ (1986) Medium-depth chemical peeling: digging beneath the surface. J Dermatol Surg Oncol 12(12): 1245—1246
Baker TJ, Gordon HL, Mosienko P et al (1974) Long-term histological study of skin after chemical face peeling. Plast Reconstr Surg 53:522
Behin F, Feuerstein SS, Marovitz WF (1977) Comparative histological study of minipig skin after chemical peel and dermabrasion. Arch Otolaryngol 103:271-277
Van Scott EJ, Yu RJ (1984) Hyperkeratinization, comeocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol 11(5 Pt 1):867—879
Moy LS, Howe K, Moy RL (1996) Glycolic acid modulation of collagen production in human skin fi broblast cultures in vitro. Dermatol Surg 22(5):439 441
Моу LS, Peace S, Моу RL (1996) Comparison of the effect of various chemical peeling agents in a mini-pig model. Dermatol Surg 22(5)1429-432
Newman N, Newman A, Moy LS, Babapour R, Harris AG, Moy RL (1996) Clinical improvement of photoaged skin with 50% glycolic acid. A double-blind vehicle-controlled study. Dermatol Surg 22(5)1455 460
Piacquadio D, Dobry M, Hunt S, Andree C, Grove G, Hollenbach KA (1996) Short contact 70% glycolic acid peels as a treatment for photodamaged skin. A pilot study. Dermatol Surg 22(5)1449—452
Kligman D, Kligman AM (1998) Salicylic acid peels for the treatment of photoaging. Dermatol Surg 24(3)1325-328
Gladstone HB, Nguyen SL, Williams R, Ottomeyer T, Wortzman M, Jeffers M, Moy RL (2000) Efficacy of hydroquinone cream (USP 4%) used alone or in combination with salicylic acid peels in improving photodamage on the neck and upper chest. Dermatol Surg 26(4)1333-337
Dinner ML Artz JS (1998) The art of the trichloroacetic acid chemical peel. Clin Plast Surg 25(l):53-62
Matarasso SL, Glogau RG (1991) Chemical face peels. Dermatol Clin 9(1)1131-150
Monheit GD (1989) The Jessner’s + TCA peel: a mediumdepth chemical peel. J Dermatol Surg Oncol 15(9):945-950
Coleman WP 3rd, Futrell JM (1994) The glycolic acid trichloroacetic acid peel. J Dermatol Surg Oncol 20(1)176-80
Tse Y, Ostad A, Lee HS, Levine VJ, Koenig K, Kamino H, Ashinoff R (1996) A clinical and histologic evaluation of two medium-depth peels. Glycolic acid versus Jessner’s trichloroacetic acid. Dermatol Surg 22(9)1781-786
El Samahy MH, Ghoz MM, Ramzy N (1998) Morphological investigation of chemical peel on photodamaged facial skin. Int J Cosmet Sci 20(5)1269-282
Zezer E, Erbil H, Kurumlu Z, Tastan HB, Etikan I (2007) A comparative study of focal medium-depth chemical peel versus cryosurgery for the treatment of solar lentigo. Eur J Dermatol 17:26-29
Lawrence N, Cox SE, Cockerell CJ, Freeman RG, Cruz PD Jr (1995) A comparison of the efficacy and safety of Jessner’s solution and 35% trichloroacetic acid vs. 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol 131:176-181
Ghersetich I, Brazzini B, Peris K, Cotellessa C, Manunta T, Lotti T (2004) Pyruvic acid peels for the treatment of photoaging. Dermatol Surg 30(1)132-36
Berardesca E, Cameli N, Primavera G, Carrera M (2006) Clinical and instrumental evaluation of skin improvement after treatment with a new 50% pyruvic acid peel. Dermatol Surg 32(4)1526-531
Alfonso-Lebrero JL et al (2003) Photoprotective properties of a hydrophilic extract of the fem polypodium leucotomos on human skin cells. J Photochem Photobiol В 70( 1):31—37
Amer M, Metwalli M (2000) Topical liquiritin improves melasma. Int J Dermatol 39:299-301
American Society of Aesthetic Plastic Surgery 1997-2007 statistics found at http://www.sur-gery.org/download/2007 stats.pdf. Accessed October 22, 2009
Ando H, Ryu A, Hashimoto A et al (1998) Linoleic and a-linoleic acid lightens ultraviolet-induced hyperpigmentation of the skin. Arch Dermatol Res 290:375-381
Angsuwarangsee S, Polnikom N (2003) Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-faced design. Dermatol Surg 29:59-64
Balina LM, Graupe К (1991) The treatment of melasma: 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 30:893-895
Balkrishnan R, Kelly AP, McMichael A et al (2004) Improved quality of life with effective treatment of facial melasma: the Pigment trial. J Drugs Dermatol 3:377-381
Baran R, Maibach HL (1998) Textbook of cosmetic dermatology, 2nd edn. Martin Dunitz, London
Baumann L, Saghari S (2009) Chemical peels. In: Bauman L (ed) Cosmetic dermatology principles and practice, 2nd edn. McGraw Hill, New York
Berardesca Е, Cameli N, Primavera G et al (2006) Clinical and instrumental evaluation of skin improvement after treatment with a new 50% pyruvic acid peel. Dermatol Surg 32:526-531
Berson DS, Cohen JL, Rendon MI et al (2009) Clinical role and application of superfi cial chemical peels in today’s practice. J Drugs Dermatol 8(9):803—811
Bissett DL, Miyamoto K, Sun P et al (2004) Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci 26(5):231-238
Bissett DL, Oblong JE, Berge CA (2005) Niacinamide: a В vitamin that improves aging facial skin appearance. Dermatol Surg 31(7): 860-865
Bissett DL, Robinson LR, Raleigh PS et al (2007) Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol 6(l):20-26
Bocchietto E, Pecis L, D’Abrosca F et al (2001) In vitro testing of innovative depigmenting and low toxicity topic compositions. Pigment Cell Res 14:405
Bolognia JL, Pawelek JM (1988) Biology of hypopigmentation. J Am Acad Dermatol 19:217-255
Brigand S, Camera E, Picardo M (2003) Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 16(2): 101-110
Brody HJ (1996) Chemical peeling and resurfacing, 2nd edn. Mosby Year Book, New York
Casintahan FA (2008) Correlation of Wood’s lamp and histologic findings in the classifi cation of melasma among Filipinos. Presented in the 3rd Meeting of the Pigmentary Disorders Advisory Board of the Philippines May 2008. unpublished
Cestari T, Arellano I, Hexsel D et al (2009) Melasma in Latin America: options for therapy and treatment algorithm. J Eur Acad Dermatol Venereol 23:760-772
Cestari TF, Hexsel D, Viegas ML et al (2007) Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. Br J Dermatol 156(S1): 13—20
Chakraborty AK, Funasaka Y, Komoto M et al (1998) Effect of arbutin on melanogenic proteins in human melanocytes. Pigment Cell Res 11:206-212
Cho Y, Kim KH, Shim JS et al (2008) Inhibitory effects of Macelignan isolated from Myristica fragrans HOUTT. on melanin biosynthesis. Biol Pharm Bull 31 (5):986-989
Choi S, Park YI, Lee SK et al (2002) Aloesin inhibits hyperpigmentation induced by UV radiation. Clin Exp Dermatol 27(6):513—515
Cotellessa C, Peris K, Onorati MT et al (1999) The use of chemical peelings in the treatment of different cutaneous hyperpigmentations. Dermatol Surg 25:450^154
Cuce LC, Bertino MC, Scattone LK et al (2001) Tretinoin peeling. Dermatol Surg 27:12-14
De Padova MP, Bellavista S, Tosti A (2007) Peel with pyruvic acid: the new formulation in gel. J Am Acad Dermatol 56(S2):AB17
Dogra S, Kanwar AJ, Parsad D (2002) Adapalene in the treatment of melasma: a preliminary report. J Dermatol 29:539-540
Draelos Z (2007) Skin lightening preparations and the hydroquinone controversy. Dermatol Ther 20:308-313
Drake LA, Brody HJ (1995) American Academy of Dermatology: guidelines of care for chemical peeling. J Am Acad Dermatol 33:497-503
Ennes SBP, Paschoalick RC, De Avelar M et al (2000) A double-blind, comparative, placebo-controlled study of the efficacy and tolerability of 4% hydroquinone as a depigmenting agent in melasma. J Dermatol Treat 11:173-179
Erbil H, Sezer E, Tastan В et al (2007) Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. J Dermatol 34(l):25-30
Espinal-Perez LE, Moncada B, Castanedo-Cazares JP (2004) A double-blind randomized trial of 5% ascorbic acid versus hydroquinone in melasma. Int J Dermatol 43:604-607
Fleischer AB, Schwartzel EH, Colby SI et al (2000) The combination of 2% 4-hydroxyani-sole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies. J Am Acad Dermatol 42:459-467
Franchi J, Coutadeur MC, Marteau C et al (2000) Depigmenting effects of calcium D-Pantetheine-S-Sulfonate on human melanocytes. Pigment Cell Res 13:165-171
Freedman BM, Rueda-Pedraza E, Waddell SP (2001) The epidermal and dermal changes associated with microdermabrasion. Dermatol Surg 27:1031-1033
Fulton JE Jr (2006) Jessner’s peel. In: Rubin MG (ed) Chemical peels. Elsevier Saunders, Philadelphia
Funasaka Y, Komoto M, Ichihashi M (2000) Depigmenting effect of alpha-tocopheryl ferulate on normal human melanocytes. Pigment Cell Res 13(S8): 170-174
Garcia A, Fulton JE Jr (1996) The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 22:443-447
Gilchrest BA, Blog FB, Szabo G (1979) Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol 73:141-143
Goh CL, Diova CN (1999) A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary Dermatological Referral Centre in Singapore. Sing Med J 40:455^458
Graupe K, Verallo-Rowell VM, Verallo V et al (1996) Combined use of 20% azelaic acid cream and 0.05% tretinion cream in the topical treatment of melasma. J Dermatol Treat 7:235-237
Grekin RC, Shelton RM, Geisse JK et al (1993) 510 run pigmented lesion dye laser: its characteristics and clinical uses. J Dermatol Surg Oncol 19:380-387
Griffiths CEM, Finkel LJ, Ditre CM et al (1993) Topical tretinoin (retinoic acid) improves melasma: a vehicle-controlled, clinical trial. Br J Dermatol 129:415—421
Grimes PE (1995) Melasma: etiologic and therapeutic considerations. Arch Dermatol 131:1453-1457
Grimes PE (1999) The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 25:18-22
Grimes PE, Yamada N, Bhawan J (2005) Light microscopic, immunohistochemical, and ultra-structural alterations in patients with melasma. Am J Dermatopath 27:96-101
Grimes P, Kelly P, Toork H et al (2006) Community-based trial of a triple-combination agent for the treatment of facial melasma. Cutis 77:177-184
Guevara IL, Pandya AG (2003) Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma. Int J Dermatol 42:966-972
Haddad AL, Matos LF, Brunstein F et al (2003) A clinical, prospective, randomized, doubleblind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol 42:153-156
Hakozaki T, Minwalla L, Ang JZ et al (2002) The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 147:20-31
Hanamura T, Uchida E, Aoki H (2008) Skinlightening effect of a polyphenol extract from Acerola (Malpighia emarginata DC.) fruit on UV-induced pigmentation. Biosci Biotechnol Biochem 72(12):3211-3218
Handog EB et al (2005) A prospective randomized double blind placebo controlled trial on the efficacy of vitamin C solution applied using iontophoresis technology in the treatment of melasma in Filipino women. RITM, Philippines, unpublished
Handog EB et al (2005) A prospective randomized double blind placebo controlled trial on the effi cacy of Tretinoin 0.1% gel applied using iontophoresis technology in the treatment of melasma in Filipino women. RITM, Philippines, unpublished
Handog EB. Galang DA, De Leon-Godinez MA et al (2009) A randomized double-blind placebo controlled trial of oral procyanidin with vitamins A, С, E for melasma among Filipino women. Int J Dermatol 48(8):896-901
Handog EB, Vitug RL, Masa EJ et al (2005) A prospective, randomized, double-blind, placebo controlled trial on the effi cacy of 8% indomethacin cream in the treatment of melasma in Filipino women. RITM, Philippines
Hermanns JF, Petit L, Pierard-Franchimont C et al (2002) Assessment of topical hypopigmenting agents on solar lentigines of Asian women. Dermatology 204: 281-286
Hernandez-Perez E, Ibiett EV (2001) Gross and microscopic findings in patients undergoing microdermabrasion for facial rejuvenation. Dermatol Surg 27:637-648
Ho SGY, Chan HL (2009) The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases. Am J Clin Dermatol 10(3): 153—168
Housman TS, Hancox JG, Mir MR et al (2008) What specialties perform the most common outpatient cosmetic procedures in the United States? Dermatol Surg 34(1): 1—7
Hughes BR (1987) Melasma occurring in twin sisters. J Am Acad Dermatol 17:841
Huh CH, Seo KI, Park JY et al (2003) A randomized double blind placebo controlled trial of vitamin C iontophoresis in melasma. Dermatology 206:316-320
Hurley ME, Guevara IL, Gonzales RM et al (2002) Efficacy of glycolic acid peels in the treatment of melasma. Arch Dermatol 138:1578-1582
Hyun SK, Lee WH, Jeong DM et al (2008) Inhibitory effects of kurarinol, kuraridinol, and trifolirhizin from Sophora flavescens on tyrosinase and melanin synthesis. Biol Pharm Bull 31(1): 154—158
Im S, Kim J, On WY et al (2002) Increased expression of alpha melanocyte-stimulating hormone in the lesional skin of melasma. Br J Dermatol 146:165 167
lorizzo M, Tosti A, De Padova M (2006) Melasma. In: Tosti AT, Grimes PE, De Padova MP (eds) Color atlas of chemical peels. Springer, New York
Javaheri SM, Handa S, Kaur I et al (2001) Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol 40:354-357
Jimbow К (1991) N-acetyl-4-S-cystaminylphe-nol as new type of depigmenting agent for the melanoderma of patients with melasma. Arch Dermatol 127:1528-1534
Jimbow K, Obata H, Pathak MA et al (1974) Mechanism of depigmentation by hydroquinone. J Invest Dermatol 62:436-449
Kakita LS, Lowe NJ (1998) Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darkerskinned patients: a clinical comparison with hydroquinone. Clin Ther 20:960-970
Kalla G, Garg A, Kachlawa D (2001) Chemical peeling - glycolic acid versus trichoracetic acid in melasma. Indian J Dermatol Venereol Leprol 67(2):82-84
Kameyama K, Sakai C, Kondoh S et al (1996) Inhibitory effect of magnesium 1-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J Am Acad Dermatol 34:29-33
Kang HY, Hwang JS, Lee JY et al (2006) The dermal stem cell factor and c-kit are over expressed in melasma. Br J Dermatol 154:1094-1099
Kang WH, Chun SC, Lee S (1998) Intermittent therapy for melasma in Asian patients with combined topical agents retinoic acid, hydroquinone and hydrocortisone: clinical and histological studies. J Dermatol 25:587-596
Kang WH, Yoon KH, Lee ES et al (2002) Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 146:228-237
Kanwar AJ, Dhar S, Kaur S (1994) Treatment of melasma with potent topical corticosteroids. Dermatology 188:170-172
Kauvar ANB, Dover JS (2001) Facial skin rejuvenation: laser resurfacing or chemical peel: choose your weapon. Dermatol Surg 27:209-212
Keeling J, Cardona L, Benitez A et al (2008) Mequinol 2%/ Tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature. Cutis 81:179-183
Khemis A, Kaiafa A, Queille-Roussel C et al (2007) Evaluation of effi cacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Br J Dermatol 156:997-1004
Khunger N, Sarkar R, Jain RK (2004) Tretinoin Peels versus glycolic acid peels in the treatment of melasma in dark skinned patients. Dermatol Surg 30:756-760
Kim YM, Yun J, Lee CK et al (2002) Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J Biol Chem 277(18): 16340-16344
Kimbrough-Green CK, Griffiths CEM, Finkel LJ et al (1994) Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 130:727-733
Kligman AM, Willis I (1975) A new formula for depigmenting human skin. Arch Dermatol 111:40-48
Kong YH, Jo YO, Cho CW et al (2008) Inhibitory effects of cinnamic acid on melanin biosynthesis in skin. Biol Pharm Bull 31(5):946-948
Kopera D, Hohenleutner U (1995) Ruby laser treatment of melasma and postinfl ammatory hyperpigmentation. Dermatol Surg 21:990-995
Kunachak S, Leelaudomlipi P, Wongwaisayawan S (2001) Dermabrasion: a curative treatment for melasma. Aesthetic Plast Surg 25:114-117
Lawrence N, Cox SE, Brody HJ (1997) Treatment of melasma with Jessner’s solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood’s light examination. J Am Acad Dermatol 36:589-593
Lee GY, Kim HJ, Whang KK (2002) The effect of combination treatment of the recalcitrant pigmentary disorders with pigmented laser and chemical peeling. Dermatol Surg 28:1120-1123
Leveque JL, Corcuff P, Rougier A et al (2002) Mechanism of action of lipophilic salicyclic acid derivative on normal skin. Eur J Dermatol 12(4):XXXV-XXXVIII
Levin C, Maibach H (2001) Exogenous ochronosis: an update on clinical features, causative agents and treatment options. Am J Clin Dermatol 2:213-217
Liberman R, Moy L (2008) Receptor Expression in melasma: results from facial skin of affected patients. J Drugs Dermatol 7(5):463-465
Lim JTE (1999) Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg 25:282-284
Lim JTE, Tham SN (1997) Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg 23(3): 177-179
Lin JY, Lim JT, Chan HL (2009) Treatment of melasma. In: Alam M, Bhatia AC, Kundu RV et al (eds) Cosmetic dermatology in skin of colour. McGraw-Hill, New York
Lufti RJ, Fridmanis M, Misiunas AL et al (1985) Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab 61:8-31
Manaloto RM, Alster T (1999) ErbiunrYAG laser resurfacing for refractory melasma. Dermatol Surg 25:121-123
Menter A (2004) Rationale for the use of topical corticosteroids in melasma. J Drugs Dermatol 3(2): 169-174
Middelkamp-Hup MA, Pathak MA, Parrado C et al (2004) Orally administered polypodium leucotomos extract decreases ultraviolet induced damage of human skin. J Am Acad Dermatol 51 (6):910—918
Monheit GD, Kayal JD (2003) Chemical peeling. In: Nouri K, Leal-Khouri S (eds) Techniques in dermatologic surgery. Mosby, Philadelphia
Moseley H, Cameron H, MacLeod T et al (2001) New sunscreens confer improved protection for photosensitive patients in the blue light region. Br J Dermatol 145:789-794
Ni Z, Mu Y, Gulati О (2002) Treatment of melasma with Pycnogenol. Phytother Res 16:567-571
Nicolaidou E, Antoniou C, Katsambas AD (2007) Origin, clinical presentation, and diagnosis of facial hypermelanoses. Dermatol Clin 25:321-326
Njoo MD, Menke HE, Pavel S et al (1997) N-acetylcystein as a bleaching agent in the treatment of melasma. J Eur Acad Dermatol Venereol 9:86-87
Ogden S, Grifii ths TW (2008) A review of minimally invasive cosmetic procedures. Br J Dermatol 159(5): 1036-1050
Packer L, Rimbach G, Virgili F (1999) Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (pinus maritima) bark. Free Radic Biol Med 27:702-724
Packer L, Witt H, Tritscheler H (1995) Lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227-250
Paine C et al (2001) An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. J Invest Dermatol 116(4):587-595
Palmieri L, Mameli M, Ronca G (1999) Effect of resveratrol and some other natural compounds on tyrosine kinase activity and on cytolysis. Drugs Exp Clin Res 25:79-85
Palumb A, Ischia M, Misuraca G et al (1991) Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta 1073:85-90
Pandya AG, Guevara IL (2000) Disorders of pigmentation. Dermatol Clin 18:91-98
Perez-Bernal A, Munoz-Perez MA, Camacho F (2000) Management of facial hyperpigmentation. Am J ClinDermatol 1:261-268
Piamphongsant T (1998) Treatment of melasma: a review with personal experience. Int J Dermatol 37:897-903
Piamphongsant T (2002) Practical dermatology. Year Book Publisher, Bangkok
Pineda RT, Chan G, Gabriel T (2006) A randomized double blind placebo controlled comparative study on the safety and efficacy of 0.25% tetrahydrocurcumin (Turmeric) cream as depigmenting agent against 4% hydroquinone cream. RITM, Philippines, unpublished
Ponzio HA, Favaretto AL, Rivitti EA (2007) Proposal of a quantitative method to describe melasma distribution in women. J Cosmet Dermatol 20:103-111
Rabe et al (2006) Photoaging: mechanisms and repair. J Am Acad Dermatol 55:1-19
Rendon M, Bemeburg M, Arellano I et al (2006) Treatment of melasma. J Am Acad Dermatol 54(5):S272-S281
Rigopoulos D, Gregoriou S, Katsambas A (2007) Hyperpigmentation and melasma. J Cos-met Dermatol 6:195-202
Roberts WE (2002) Microdermabrasion dual therapy. Microdermabrasion Skin and Allergy News 33:42
Roberts WE (2004) Chemical peeling in ethnic/ dark skin. Dermatol Ther 17:196-205
Roberts WE (2009) Melasma. In: Kelly AP, Taylor SC (eds) Dermatology for skin of color. McGraw-Hill, New York
Sanchez NP, Pathak MA, Sato SS et al (1982) Circumscribed dermal melaninoses: classification, light, histochemical, and electron microscopic studies on three patients with the erythema dyschromicum perstans type. Int J Dermatol 21:25-31
Sarkar R, Bhalla M, Kanwar AJ (2002) A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in darkskinned patients. Dermatology 205:249-254
Sarkar R, Kaur C, Bhalia M et al (2002) The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark skinned patients: a comparative study. Dermatol Surg 28:828-832
Scherdin U, Burger A, Bielfeldt S et al (2008) Skinlightening effects of a new face care product in patients with melasma. J Cosmet Dermatol 7:68-75
Shahrir M, Saadiah S, Sharifah 1 et al (2004) The efficacy and safety of French Maritime pine bark extract in the form of MSS Complex Ac-tinosome on melasma. Int Med J 3(2): 130-132
Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA (2005) Lactic acid as a new therapeutic peeling agent in melasma. Dermatol Surg 31:149-154
Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA (2006) Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner’s solution chemical peels. Dermatol Surg 32:1429-1436
Shimizu K, Kondo R, Sakai К et al (2001) Novel vitamin E derivative with 4-substi-tuted resorcinol moiety has both antioxidant and tyrosinase inhibitory properties. Lipids 36(12): 1321-1326
Sialy R, Hasan I, Kaur I et al (2000) Melasma in men: a hormonal profi le. J Dermatol 27:64—65
Soliman MM, Ramadan SA, Bassiouny DA et al (2007) Combined trichoracetic acid peel and topical ascorbic acid versus trichloracetic acid peel alone in the treatment of melasma: a comparative study. J Cosmet Dermatol 6(2):89-94
Stevens A, Raferty J (1997) Health care needs assessment. Radcliffe Medical Press, New York
Taylor MB (1999) Summary of mandelic acid for the improvement of skin conditions. Cosmet Dermatol 12:28
Taylor CR, Anderson RR (1994) Ineffective treatment of refractory melasma and post-inflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 20:592-597
Taylor SC, Torok H, Jones T et al (2003) Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis 72:67-72
Torok H (2005) A large 12 month extension study of an 8-week trial to evaluate the safety and effi cacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. J Drugs Dermatol 4:592-597
Torok HM, Jones T, Rich P et al (2005) Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. Cutis 75:57-62
Tosti A, De Padova MP, Venture N et al (2005) New combined peel in Melasma. J Am Acad Dermatol 52(3): 169
Usuki A, Ohashi A, Sato H et al (2003) The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells. Exp Dermatol 12:43-50
Varma S, Roberts DL (1999) Melasma of the arms associated with hormone replacement therapy. Br J Dermatol 141:592
Vazquez M, Maldonado H, Benmaman C et al (1988) Melasma in men: a clinical and histologic study. Int J Dermatol 27:25-27
Verrallo-Rowell VM (2001) Facial hyperpigmentation problems common to multi-heritage Asian skin phototypes in the tropics: melasma, freckles, PIH, liver spots and warts: Q&A. In: Skin in the tropics. The House Printers, Philippines
Verallo-Rowell VM, Verallo V, Graupe К et al (1989) Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol Suppl (Stockh) 143(suppl):58-61
Verallo-Rowell VM et al (2002) SPF and PFA of colored cosmetics. In: Skin in the tropics: sunscreens and hyperpigmentations. Anvil, Philippines
Wang CC, Hui CY, Sue YM et al (2004) Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg 30:1196-1200
Wanitphakdeedecha R, Eimpunth S, Manuskiatti W (2009) The effects of tetrahydrocurcumin in curmin cream on the hydration, elasticity, and color of human skin. J Am Acad Dermatol 60(3):AB83
Westerhof W, Njoo MD (2003) Bleaching agents. In: Katsambas AD, Lotti TM (eds) European handbook of dermatological treatments, 2nd edn. Springer, Berlin
Yokota T, Nishio H, Kubota Y et al (1998) The inhibitory effect of glabridin from liquorice extracts on melanogenesis and infl animation. Pigment Cell Res 11:355-361
Yoshimura K, Momosawa A, Alba E et al (2003) Clinical trial of bleaching treatment with 10% all trans retinol gel. Dermatol Surg 29:155-160
Yoshimura M, Watanabe Y, Kasai К et al (2005) Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation. Biosci Biotechnol Biochem 69(12):2368-2373
Zakapoulu N, Kontochristopoulos MD, Kontochristopoulos G (2006) Superficial chemical peels. J Cosmet Dermatol 5:246-253
Noblesse Е, Nizard С, Cario-Andre М et al (2006) Skin ultrastructure in senile lentigo. Skin Pharmacol Physiol 19:95-100
Pierard GE, Pierard-Franchimont C, Laso Dosal F et al (1991) Pigmentary changes in skin senescence. J Appl Cosmetol 9:63-67
Nordlund JJ, Boissy RE, Hearing VJ et al (2006) The pigmentary system, 2nd edn. Blackwell Publishing, Oxford, p 829
Katsambas AD, Stratigos AJ (2001) Depigmenting and bleaching agents: coping with hyperpigmentation. Clin Dermatol 19:483-^188
Humphreys TR, Werth V, Dzubow L, KJingman A (1996) Treatment of photodamaged skin with TCA and topical tretinoin. J Am Acad Dermatol 34:638-644
Sezer E, Erbil H, Kurumulu Z et al (1997) A comparative study of focal medium-depth chemical peel versus cryosurgery for the treatment of solar lentigo. Eur J Dermatol 17:26-29
Zouboulis CC, Rosenberger AD, Adler Y, Orfa-nos CE (1999) Treatment of solar lentigo with cryosurgery. Acta Derm Venereol 79:489-490
Rinaldi F (2008) Lasers: a review. Clin Dermatol 26:590-601
Halder RM, Grimes РЕ, McLaurin CI, Kreiss MA, Kenney JA (1983) Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis 32:378-380
Pandya AG, Guevara IL (2000) Disorders of hyperpigmentation. Dermatol Clin 18( 1):91—98
McBumey El (2002) Side effects and complications of laser therapy. Dermatol Clin 20(l):165-176
Nordlund JJ, Abdel-Malek ZA (1988) Mechanisms of postinflammatory hyperpigmentation and hypopigmentation. Prog Clin Biol Res 256:219-236
Johansson O, Ljungberg A, Han SW, Vaalasti A (1991) Evidence for gamma-melanocyte stimulating hormone containing nerves and neutrophilic granulocytes in the human skin by indirect immunofluorescence. J Invest Dermatol 96(6):852-856
Morelli JG, Yohn JJ, Lyons MB, Murphy RC, Norris DA (1989) Leukotrienes C4 and D4 as potent mitogens for cultures human neonatal melanocytes. J Invest Dermatol 93(6):719-722
Tomita Y, Iwamoto M, Masuda T, Tagami H (1987) Stimulatory effect of prostaglandin E2 on the confi guration of normal human melanocytes in vitro. J Invest Dermatol 89(3):299—301
Tomita Y, Maeda K, Tagami H (1992) Melanocytestimulation properties of arachidonic acid metabolites: possible role of post-inflammatory pigmentation. Pigment Cell Res 5(5 pt 2):357—361
Noto G, Pravata G, Arico M (1998) Reticulate postinflamatory hyperpigmentation with band-like mucin deposition. Int J Dermatol 37(II):829-832
Bulengo-Ransby SM, Griffiths C, Kimbrough-Green CK, Finkel LJ, Hamilton TA, Ellis CN, Voorhees JJ (1993) Topical tretinion (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med 328:1438-1443
Grimes PE, Callender VD (2003) Tazarotene cream 0.1% in the treatment of facial postinflammatory hyperpigmentation associated with acne vulgaris: a two-center, double-blind, randomized, vehicle - controlled study. Poster presentation at the 61st annual meeting of the American Academy of Dermatology, San Francisco, 21-26 March 2003
Jacyk WK, Mpofu P (2001) Adapalene gel 0.1 % for topical treatment of acne vulgaris in African patients. Cutis 68:48-54
Kligman AM, Willis 1 (1975) A new formula for depigmenting human skin. Arch Dermatol 111:40-48
Bums R, Prevost-Blank PL, Lawry MA, Lawry ТВ, Faria DT, Fivenson DP (1999) Glycolic acid peels for postinflammatory hyperpigmentation in black patients. Dermatol Surg 25:18-22
Yoshimura K, Harii K, Aoyama T, Iga T (2000) Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals. Plast Reconstr Surg 105:1097-1110
Cook-Bolden FE (2004) The efficacy and tolerability of a combination cream containing 4% hydroquinone in the treatment of postinflammatory hyperpigmentation in skin types IV-V1. J Cosmet Dermatol 17(3): 149-155
Grimes PE (2000) Agents for ethnic skin peeling. Dermatol Ther 30:159-164
Callender VD (2004) Acne in ethnic skin: special considerations for therapy. Dermatol Ther 17:184-195
Grimes PE (1999) The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 25:18-22
Nanni CA, Alster TS (1999) Laser-assisted hair removal: side effects of Q-switched Nd:Yag, long-pulsed ruby, and alexandrite lasers. J Am Acad Dermatol 41(2 ptl): 165—171
Tanzi EL, Alster TS (2003) Single-pass carbon dioxide versus multiple-pass Er: YAG laser skin resurfacing: a comparison of postoperative wound healing and side-effect rates. Dermatol Surg 29(l):80-84
Graber EM, Tanzi EL, Alster TS (2008) Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg 34(3):301—305
Aldraibi MS, Touma DJ, Khachemoune A (2007) Hair removal with the 3-mec alexandrite laser in patients with skin types IV-VI: efficacy, safety, and the role of topical steroids in preventing side effects. J Drugs Dermatol 6(l):60-66
Cho SB, Park SJ, Kim JS, Kim MJ, Bu TS (2009) Treatment of post-inflammatory hyperpigmentation using a 1064 nm QS Nd:Yag laser with low fluence: report of three cases. J Eur Acad Dermatol Venereol 23:1206-1207
Burton JL, Cunliffe WJ, Stafford I, Shuster S (1971) The prevalence of acne vulgaris in adolescence. Br J Dermatol 85:119- 126
Rademaker M, Garioch JJ, Simpson NB (1989) Acne in schoolchildren: no longer a concern for dermatologists. BMJ 298:1217-1219
Cunliffe WJ, Gould DJ (1979) Prevalence of facial acne vulgaris in late adolescence and in adults. BMJ 1:1109-1110
Layton AM, Henderson CA, Cunliffe WJ (1994) A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 19:303-308
Holland DB, Jeremy AHT, Roberts SG, Seu-keran DC, Layton AM (2004) Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol 150:72-81
Alam M, Dover JS (2006) Treatment of acne scarring. Skin Therapy Lett 11:7-9
Jacob CI, Dover JS, Kaminer MS (2001) Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol 45:109-117
Kadunc BV, Trindade de Almeida AR (2003) Surgical treatment of facial acne scars based on morphologic classification: a Brazilian experience. Dermatol Surg 29:1200-1209
Goodman GJ, Baron JA (2007) The management of postacne scarring. Dermatol Surg 33:1175-1188
Mackee GM, Karp FL (1952) The treatment of post acne scars with phenol. Br J Dermatol 64:456-459
Kurtin A (1953) Corrective surgical planning of skin: new technique for treatment of acne scars and other skin defects. AMA Arch Dermtol Syphilol 68:389-397
Malherbe WD, Davies DS (1971) Surgical treatment of acne scarring, by a dermatome. Plast Reconstr Surg 47:122-126
Orentreich N (1969) Dermabrasion. J Am Med Womens Assoc 24:331-336
Kurtin A(1968) Dermabrasion. Arch Dermatol 98:87
Rattner R, Rein CR (1955) Treatment of acne scars by dermabrasion; rotary brush method. J Am Med Assoc 159:1299-1301
Knapp TR, Kaplan EN, Danieks JR (1977) Injectable collagen for soft tissue augmentation. Plast Reconstr Surg 60:398-405
Stegman SJ, Tromovitch TA (1980) Implantation of collagen for depressed scars. J Dermatol Surg Oncol 6:450-453
Vamavides CK, Forster RA, Cunliffe WJ (1987) The role of bovine collagen in the treatment of acne scars. Br J Dermatol 116:199-206
Thrimbke JR (1983) Dermal overgarfting in dermatology. J Dermatol Surg Oncol 9:987-993
Besecker B, Hart CG (1999) A new treatment option for acne scars: allograft dermis. Dermatol Nurs 11:111-114
Goodman G (1997) Laser-assisted dermal grafting for the correction of cutaneous contour defects. Dermatol Surg 23:95-99
Mancuso A, Farber GA (1991) The abraded punch graft for pitted facial scars. J Dermatol Surg Oncol 17:32-34
Sulamanidze MA, Salti G, Mascceti M, Sula-manidze GM (2000) Wire scalpel for surgical correction of soft tissue contour defects by subcutaneous dissection. Dermatol Surg 26:146-150
Garrett AB, Dufresne RG Jr, Ratz JL, Berlin AJ (1990) Carbon dioxide laser treatment of pitted acne scarring. J Dermatol Surg Oncol 16:737-740
Alster TS, West ТВ (1996) Resurfacing of atrophic facial acne scars with a high-energy, pulsed carbon dioxide laser. Dermatol Surg 22:151-154
Alster TS, McMeekin TO (1996) Improvement of facial acne scars by the 585 nm flashlamp-pumped pulsed dye laser. J Am Acad Dermatol 35:79-81
Kye YC (1997) Resurfacing of pitted facial scars with a pulsed Er:YAG laser. Dermatol Surg 23:880-883
West ТВ (1997) Laser resurfacing of atrophic scars. Dermatol Clin 15:449-457
Manusciatti W, Fitzpatrick RE, Goldman MP (2000) Treatment of facial skin using combinations of CO2, Q-switched alexandrite, flashlamp-pumped pulsed dye, and Er:YAG lasers in the same treatment session. Dermatol Surg 26:114-120
Jordan R, Cummins C, Burls A (2000) Laser resurfacing of the skin for the improvement of facial acne scarring: a systematic review of the evidence. Br J Dermatol 142:413-423
Tsai RY, Wang CN, Chan HL (1995) Aluminum oxide crystal microdermabrasion. A new technique for treating facial scarring. Dermatol Surg 21:539 542
Goodman GJ (2003) Post acne scarring: a review. J Cosmet Laser Ther 5:77-95
Fulton JE Jr (1987) Modem dermabrasion techniques: a personal appraisal. J Dermatol Surg Oncol 13:780-789
Solotoff SA (1986) Treatment for pitted acne scarring - postauricular punch grafts followed by dermabrasion. J Dermatol Surg Oncol 12:1079-1084
Grevelink JM, White VR (1998) Concurrent use of laser skin resurfacing and punch excision in the treatment of facial acne scarring. Dermatol Surg 24:527-530
Fulton JE Jr (1996) Dermabrasion, chemabra-sion, and laserabrasion. Historical perspectives, modem dermabrasion techniques, and future trends. Dermatol Surg 22:619-628
Ayhan S, Baran CN, Yavuzer R, Latifoglu O, Cenetoglu S, Baran NK (1998) Combined chemical peeling and dermabrasion for deep acne and posttraumatic scars as well as aging face. Plast Reconstr Surg 102(4): 1238-1246
Horton CE, Sadove RC (1987) Refinements in combined chemical peel and simultaneous abrasion of the face. Ann Plast Surg 19(6):504-511
Fintsi Y, Kaplan H, Landau M (1999) Whether to peel or laser for acne scarring and hyperpigmentation. Int J Cosmet Surg 7:67-70
Fintsi Y (1998) Exoderm chemabrasion: original method for the treatment of facial acne scars. Int J Cosmet Surg 6:111-114
Wang KK, Lee M (1999) The principle of a three-staged operation in the surgery of acne scars. J Am Acad Dermatol 40(1):95-97
Atzori L, Brundu MA, Orru A, Biggio P (1999) Glycolic acid peeling in the treatment of acne. J Eur Acad Dermatol Venereol 12:119-122
Lee JB, Chung WG, Kwahck H, Lee KH (2002) Focal treatment of acne scars with trichloroacetic acid: chemical reconstraction of skin scars method. Dermatol Surg 28(11): 1017-1021
Al-Waiz MM, Al-Sharqi Al (2002) Mediumdepth chemical peels in the treatment of acne scars in dark-skinned individuals. Dermatol Surg 28(5):383-387
Landau M (2005) Advances in deep chemical peels. Dermatol Nurs 17:438 441
Park JH, Choi YD, Kim SW et al (2007) Effectiveness of modified phenol peel (Exoderm) on facial wrinkles, acne scars and other skin problems of Asian patients. J Dermatol 34:17-24
Bagatin E, Dos Santos Guadanhim LR, Yarak S, Kamamoto CS, De Almeida FA (2010) Dermabrasion for acne scars during treatment with oral isotretinoin. Dermatol Surg 36(4):483-489
Ayres S Jr (1988) Acne rosacea in blacks - were Demodex mites found in any patients? J Am Acad Dermatol 18:387-388
Rosen T, Stone MS (1987) Acne rosacea in blacks. J Am Acad Dermatol 17:70-73
Sibenge S, Gawkrodger DJ (1992) Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol 26:590-593
Marks R (1968) Concepts in the pathogenesis of rosacea. Br J Dermatol 80:170-177
Basta-Juzbasic A, Subic JS, Ljubojevic S (2002) Demodex folliculorum in development of dermatitis rosaceiformis steroidica and rosacea-related diseases. Clin Dermatol 20:135-140
Leyden JJ, Thew M, Kligman AM (1974) Steroid rosacea. Arch Dermatol 110:619-622
Reifler DM, Verdier DD, Davy CL, Mostow ND, Wendt VE (1987) Multiple chalazia and rosacea in a patient treated with amiodarone. Am J Ophthalmol 103:594-595
Lilbbe J, Stucky L, Saurat JH (2003) Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream. Dermatology 207:205-207
Kaufmann-Wolf M (1925) Uber regelmassiges vorkommen von Demodex folliculorum in den pusteln von rosacea pustulosa. Derm Wschr 81:1095-1103
Forton F, Seys В (1993) Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol 128:650-659
Georgala S, Katoulis AC, Kylafis GD, Koumantaki-Mathioudaki E, Georgala C, Aroni К (2001) Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. JEADV 15:441^144
Roihu T, Kariniemi AL (1998) Demodex mites in acne rosacea. J Cutan Pathol 25:550-552
Rufli T, Mumcuoglu Y, Cajacob A, Buchner S (1981) Demodex folliculorum : zur atiopatho-genese und therapie der rosazea und der perioralen dermatitis. Dermatologica 162:12-26
Bonnar E, Eustace P, Powell FC (1993) The Demodex mite population in rosacea. J Am Acad Dermatol 28:443-448
Erbagci Z, Ozgozta?i О (1998) The significance of Demodex folliculorum density in rosacea. Int J Dermatol 37:421-425
Crawford GH, Pelle MT, James WD (2004) Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 51:327 341
Persi A, Rebora A (1985) Metronidazole in the treatment of rosacea. Arch Dermatol 121:307-308
Robinson TWE (1965) Demodex folliculorum and rosacea. A clinical and histological study. Arch Dermatol 92:542-544
Erel A, Oztas M, liter N, Senol E, Sultan N, Giirer MA (1995) Helicobacter pylori seroprevalence in patients with acne rosacea. JEADV 5(Suppl 1):S151
Rebora A, Drago F, Parodi A (1995) May Helicobacter pylori be important for dermatologists? Dermatology 191:6-8
Szlachcic A, Sliwowski Z, Karczewska E, Bielanski W, Pytko-Polonczyk J, Konturek SJ (1999) Helicobacter pylori and its eradication in rosacea. J Physiol Pharmacol 50:777-786
Argenziano G, Donnarumma G, lovene MR, Arnese P, Baldassarre MA, Baroni A (2003) Incidence of m\\-Helicobacter pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol 42:601-604
Giirer MA, Erel A, Erba? D, Qaglar K, Atahan C (2002) The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol 41:768—770
Szlachcic A (2002) The link between Helicobacter pylori infection and rosacea. JEADV 16:328-333
Kolibasova K, Tothova I, Baumgartner J, Filo V (1996) Eradication of Helicobacter pylori as the only successful treatment in rosacea. Arch Dermatol 132:1393
Rebora A, Drago F, Picciotto A (1994) Helicobacter pylori in patients with rosacea. Am J Gastroenterol 89:1603-1604
Utas S, Ozbakir O, Turasan A, Utas C (1999) Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol 40:433-435
Bamford J (2001) Rosacea: current thoughts on origin. Semin Cutan Med Surg 20:199-206
Sharma VK, Lynn A, Kaminski M, Vasudeva R, Howden CW (1998) A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol 93:220-222
Bamford JTM, Tilden RL, Blankush JL, Gangeness DE (1999) Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 135:659-663
Bonamigo RR, Leite CS, Wagner M, Bakos L (2000) Rosacea and Helicobacter pylori: interference of systemic antibiotic in the study of possible association. JEADV 14:424-425
Mayr-Kanhauser S, Ктапке В, Kaddu S, Mullegger RR (2001) Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole. Eur J Gastroenterol Hepatol 13:1379-1383
Jones MP, Knable AL Jr, White MJ, Durning SJ (1998) Helicobacter pylori in rosacea: lack of an association. Arch Dermatol 134:511
Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, Powell F (2002) Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 46:584-587
Sanchez J, Somolinos AL, Almodovar PI, Webster G, Bradshaw M, Powala C (2005) A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea. J Am Acad Dermatol 53:791-797
Wolf JE Jr, Kerrouche N, Arsonnaud S (2006) Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. Cutis 77(Suppl 4):3-11
Ziel K, Yelverton CB, Balkrishnan R, Feldman SR (2005) Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. J Drugs Dermatol 4:727-731
Beutner KR, Lemke S, Calvarese В (2006) A look at the safety of metronidazole 1% gel: cumulative irritation, contact sensitization, phototoxicity, and photoallergy potential. Cutis 77(Suppl 4): 12-17
Elewski BE (2007) Rosacea trial comparing twice-daily azelaic acid gel 15% with once-daily metronidazole gel 1%. Cutis 79:57-58
Liu RH, Smith MK, Basta SA, Farmer ER (2006) Azelaic acid in the treatment of papu-lopustular rosacea: a systematic review of randomized controlled trials. Arch Dermatol 142:1047-1052
Draelos ZD (2004) Noxious sensory perceptions in patients with mild to moderate rosacea treated with azelaic acid 15% gel. Cutis 74:257-260
Mills OH Jr, Kligman AM (1976) Topically applied erythromycin in rosacea. Arch Dermatol 112:553-554
Wilkin JK, DeWitt S (1993) Treatment of rosacea: topical clindamycin versus oral tetracycline. Int J Dermatol 32:65-67
Shalita A, Leyden J (2004) Mechanism-based selection of pharmacologic agents for rosacea. Cutis 73(Suppl 1):15—18
Fisher AA (1983) Adverse reactions to topical clindamycin, erythromycin and tetracycline. Cutis 32:415,419, 424, 428
Montes LF, Cordero AA, Kriner J, Loder J, Flanagan AD (1983) Topical treatment of acne rosacea with benzoyl peroxide acetone gel. Cutis 32:185-190
Breneman D, Savin R, VandePol C, Vamva-kias G, Levy S, Leyden J (2004) Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea. Int J Dermatol 43:381-387
Ozturkcan S, Ermertcan AT, Sahin MT, Afar FS (2004) Efficiency of benzoyl peroxide-erythromycin gel in comparison with metronidazole gel in the treatment of acne rosacea. J Dermatol 31:610-617
Kosak M, Yagli S, Vahapoglu G, Eksioglu M (2002) Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized doubleblind placebo-controlled study. Dermatology 205:265-270
Signore RJ (1995) A pilot study of 5 percent permethrin cream versus 0.75 percent metronidazole gel in acne rosacea. Cutis 56:177-179
Rebora A (2002) The management of rosacea. Am J Clin Dermatol 3:489-496
Pelle MT, Crawford GH, James WD (2004) Rosacea: II. Therapy. J Am Acad Dermatol 51:499-512
Blom I, Hommark AM (1984) Topical treatment with sulfur 10 per cent for rosacea. Acta Derm Venereol 64:358-359
Sauder DN, Miller R, Gratto D, Danby W, Griffiths C, Phillips SB (1997) The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (No-vacet) is demonstrated in a double-blind study. J Dermatol Treat 8:79-85
Ertl GA, Levine N, Kligman AM (1994) A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 130:319-324
Bamford JT, Elliott BA, Haller IV (2004) Tacrolimus effect on rosacea. J Am Acad Dermatol 50:107-108
Cunha PR, Rossi AB (2006) Pimecrolimus cream 1% is effective in a case of granulomatous rosacea. Acta Derm Venereol 86:71-72
Goldman D (2001) Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 44:995-998
Zuuren EJV, Graber MA, Hollis S, Chaudhry M, Gupta AK, Gover M (2005) Interventions for rosacea. Cochrane Database Syst Rev (3):CD003262
Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258-265
Berson DS, Cohen JL, Rendon MI, Roberts WE, Starker I, Wang В (2009) Clinical role and application of superficial chemical peels in today’s practice. J Drugs Dermatol 8:803-811
Lee HS, Kim IH (2003) Salicylic acid peels for the treatment of acne vulgaris in Asian patients. Dermatol Surg 29:1196-1199
Stinco G, Bragadin G, Trotter D, Pillon B, Patrone P (2007) Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne. JEADV 21:320-325
Zeigler A, Jonason AS, Leffell DJ et al (1994) Sunburn and p53 in the onset of skin cancer. Nature 372:773-776
Freeman RG (1968) Carcinogenic effect of solar radiation and prevention measures. Cancer 21:11114-11120
Barr BB, Benton EC, McLaren К et al (1989) Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 2:224-225
Glogau RG (2000) The risk of progression to invasive disease. J Am Acad Dermatol 42:23-24
Dodson JM. DeSpain J, Hewett JE et al (1991) Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 127:1029-1031
Rowert HJ, Patel MJ, Foschner T et al (2007) Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 156:8-12
Stockfleth E, Ferrandiz C, Grob J et al (2008) Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 18:651-659
de David B, Jane MM, Hughest BR (2007) Guidelines for the management of actinic keratoses. Br J Dermatol 156:222-230
Furukawa F, Yamamoto Y (2006) Recent advances in chemical peeling in Japan. J Dermatol 33:655-661
Hurwitz DJ, Pincus L, Kupper TS (2003) Imiquimod. A topically applied link between innate and acquired immunity. Arch Dermatol 139:1347-1350
Brody HJ (1997) Chemical peeling and resurfacing, 2nd edn. Mosby, St. Louis, Missouri, pp 29-38
Yamamoto Y, Ohtani T, Uede К et al (2003) Phenol and trichloroacetic acid peeling is a new tool as non-invasive therapy to the aged patients with skin cancer. J Invest Dermatol 121:1205, Abstract
Yamamoto Y, Uede K, Yonei N et al (2003) Expression of tenascin and human b-1 integrin in the skin peeled with phenol or trichloroacetic acid. Aesthet Dermatol 13:17-24
Yamamoto Y, Uede K, Ueda M et al (2002) Characterization of monoclonal anti-human skin basal cell antibody 3B 4-6 and its reactivity to the skin peeled with phenol or trichloracetic acid (TCA). Aesthet Dermatol 12:70-76
Yamamoto Y, Yonei N, Kaminaka C et al (2004) Effects of phenol peeling on dermal endothelial cells. J Dermatol Sci 35:158-161
Yamamoto Y, Uede K, Otani T et al (2006) Different apoptotic patterns observed in tissues damaged by phenol and TCA peels. J Dermatol Sci supp. 2:75-81
Stuzin JM (1998) Phenol peeling and the history of phenol peeling. Clin Plast Surg 25:1-19
Peters W (1991) The chemical peel. Ann Plast Surg 26:564-571
Truppman ES, Ellenby JD (1979) Major electrocardiographic changes during chemical peeling. Plast Reconstr Surg 63:44—48
Brodland DG, Roenigk RK (1988) Trichloroacetic acid chemexfoliation (chemical peel) for extensive premalignant actinic damage of the face and scalp. Mayo Clin Proc 63:887-896
Brody HJ, Hailey CW (1986) Medium-depth chemical peeling of the skin: a variation of superficial chemosurgery. J Dermatol Surg Oncol 12:1268-1275
Monheit GD (1989) The Jessner’s + TCA peel: a mediumdepth chemical peel. J Dermatol Surg Oncol 15:945-950
Dainichi T, Koga T, Furue M et al (2003) Paradoxical effect of trichloroacetic acid (TCA) on ultraviolet В-induced skin tumor formation. J Dermatol Sci 31:229-231
Yamamoto Y, Uede K, Yonei N et al (2007) Expression patterns of proliferating cell nuclear antigen in trichloroacetic acid peeled skin. J Dermatol 34:95-98
Kaminaka C, Yamamoto Y, Yonei N et al (2009) Phenol peels as a novel therapeutic approach for actinic keratosis and Bowen disease: prospective pilot trial with assessment of clinical, histologic, and immunohistochemical correlations. J Am Acad Dermatol 60:615-625
Kaminaka C, Yamamoto Y, Furukawa F (2007) Nevoid basal cell carcinoma syndrome successfully treated with trichloroacetic acid and phenol peeling. J Dermatol 34:841-843
Fitzpatrick RE, Tope WD, Goldman MP et al (1996) Pulsed carbon dioxide laser, trichloroacetic acid, Baker-Gordon phenol, and dermabrasion: a comparative clinical and histologic study of cutaneous resurfacing in porcine model. Arch Dermatol 32:469 471
Kligman AM, Baker TJ, Gordon HL (1985) Long-term histologic follow-up of phenol face peels. Plast Reconstr Surg 75:652-659
U.S. Census Bureau News, 2010 Census shows American diversity, March 24, 2011
Montagna W, Prota G, Kenney JA(1993) Black skin structure and function. Academic, San Diego, pp 42-45
Szabo G, Gerald AB, Patnak MA, Fitzpatrick ТВ (1969) Racial differences in the fate of melanosomes in human epidermis. Nature 222:1081-1082
Olson RL, Gaynor J, Everett MA (1973) Skin color, melanin, and erythema. Arch Dermatol 108:541-544
Kaidbey KH, Agin PP, Sayre RM, Kligman A (1979) Photoprotection by melanin - a comparison of black and Caucasian skin. J Am Acad Dermatol 1:249-260
Berardesca E, Maibach H (1996) Racial differences in skin pathophysiology. J Am Acad Dermatol 34:667-672
Grimes PE, David LT (1991) Cosmetics in blacks. Dermatol Clin 9:53-63
Halder RM, Grimes PE, McLauren C, Kress MA, Kenney JA Jr (1983) Incidence of common dermatoses in predominantly black dermatologic practice. Cutis 32:388-390
Grimes PE (2000) Skin and hair cosmetic issues in women of color. Dermatol Clin 15(4):659— 665
Grimes PE, Hunt SG (1993) Considerations for cosmetic surgery in the black population. Clin Plast Surg 20:27-34
Grimes PE (2000) Agents for ethnic skin peeling. Dermatol Ther 13:159-164
Pierce HE, Brown LA (1986) Laminar dermal reticulotomy and chemical face peeling in the black patient. J Dermatol Surg Oncol 12:69-73
Al-Waiz MM, Al-Sharqi Al (2002) Mediumdepth chemical peels in the treatment of acne scars in dark-skinned individuals. Dermatol Surg 28:383-387
Lim JT, Tham SN (1997) Glycolic acid peels in the treatment of melasma in Asian women. Dermatol Surg 20:27-34
Wang CM, Huang CL, Hu CT, Chan HL (1997) The effects of glycolic acid on the treatment of melasma among Asian skin. Dermatol Surg 23:23-29
Bums RI, Provost-Blank PC, Lawry MA et al (1997) Glycolic acid peels for post inflammatory hyperpigmentation in black patients: a comparative study. Dermatol Surg 23:171-174
Javaheri SM, Handa S, Kaur I et al (2001) Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol 40:354-357
Sarkar R, Kaur C, Bhalla M et al (2002) The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg 28:828-832
Kligman D, Kligman AM (1998) Salicylic acid peels for the treatment of photoaging. Dermatol Surg 24:325-328
Grimes PE (1999) The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 25:18-22
Lee Ho-S, Kim IH (2003) Salicylic acid peels for the treatment of acne vulgaris in Asian patients. Dermatol Surg 29:1196-1199
Lawrence NL, Cox SE, Brady HJ (1977) Treatment of melasma with Jessner’s solution verses glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood’s light examination. J Am Acad Dermatol 36:589-593
Khunger N, Sarkar R, Jain RK (2004) Tretinoin peels verses glycolic acid peels in the treatment of melasma in darkskinned patients. Dermatol Surg 25:270-273
El-Domyati MB, Attia SK, Saleh FY, Ahmad HM, Uitto JJ (2004) Trichloroacetic acid peeling versus dermabrasion: a histometric, immunohistochemical, and ultrastructural comparison. Dermatol Surg 30(2 Pt 1): 179-188
Stegman SJ (1982) A comparative histologic study of the effects of the three peeling agents and dermbrasion on normal and sun damaged skin. Aesthetic Plast Surg 6:123
Rubin MG (1995) What are skin peels? In: Winters SR, James M, Caputo GR (eds) Manual of chemical peels: superfi cial and medium depth, 1st edn. JB Lippincott Co, Philadelphia, pp 17-25
Elsaie ML, Lloyd HW (2008) Latest laser and light based advances for ethic skin rejuvenation. Indian J Dermatol Venereol Leprol 23(3):49—53
Grimes PE, Hexsel DM, Rutowitsch M (2008) The aging face in darker racial ethnic groups. In: Grimes PE (ed) Aesthetics and cosmetic surgery for darker skin types. Lippincott William and Wilkins, Philadelphia, pp 27-36
Savant SS, Mehta N (1998) Superficial and medium depth chemical peeling. In: Savant SS, Atal-Shah R, Gore D (eds) Textbook and atlas of dermatosurgery and cosmetology, 1st edn. Association of Scientifi c Cosmetologists and Dermatologists, Mumbai, pp 136-144
Nanda S, Grover C, Reddy BSN (2004) Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma. Dermatol Surg 30:385-389
Garg VK, Sarkar R, Agarwal R (2008) Comparative evaluation of benefi ciary effects of riming agents (2% hydroquinone versus 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels. Dermatol Surg 34:1032-1039
Clark CP (1996) Alpha hydroxy acids in skin care. Clin Plast Surg 23:49-56
Sarkar R, Kaur C, Bhalla M, Kanwar AJ (2002) The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg 28:828-832
Lim JT, Tham SN (1997) Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg 23:177-179
Sehgal VN, Luthra A, Aggarwal AK (2003) Evaluation of graded strength glycolic acid (GA) facial peal: an Indian experience. J Dermatol 30:758-761
Javaheri SM, Handa S, Kaur I, Kumar В (2001) Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol 40:354-357
Wang CM, Huang CL, Sindy CT, Chan HL (1997) The effect of glycolic acid on the treatment of acne in Asian skin. Dermatol Surg 23:23-29
Al-Waiz MM, Al-Sharqi Al (2002) Medium -depth chemical peels in the treatment of acne in dark-skinned individuals. Dermatol Surg 28:383-387
Monheit GD, Kayal JD (2004) Chemical peeling. In: Nouri K, Leal Khouri S (eds) Techniques in dermatologic surgery, 1st edn. Mosby, St. Louis, pp 233-244
Vedamurthy M (2004) Salicylic acid peels. Indian J Dermatol Venereol Leprol 70:136-138
Lee HS, Kim IH (2003) Salicylic acid peels for the treatment of acne vulgaris in Asian patients. Dermatol Surg 29:1196-1199
Bari AU, Iqbal Z, Rahman SB (2005) Tolerance and safety of superfi cial chemical peeling with salicylic acid in various facial dermatoses. Indian J Dermatol Venereol Leprol 71 (2):87—90
Ahn НН, Kim IH (2006) Whitening effect of salicylic acid peels in Asian patients. Dermatol Surg 32:372-375
Khunger N, Sarkar R, Jain RK (2004) Tretinoin peels versus glycolic acid peels in the treatment of melasma in dark skinned patients. Dermatol Surg 30:756-760
Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA (2005) Lactic acid as a new therapeutic peeling agent in melasma. Dermatol Surg 31:149-154
Kim SW, Moon SE, Kim JA, Eun HC (1999) Glycolic acid versus Jessner’s solution: which is better for facial acne patients? Dermatol Surg 25:270-273
Garg VK, Sinha S, Sarkar R (2009) Glycolic acid peels versus salicylic-mandelic acid peels in active acne vulgaris and post-acne scarring and hyperpigmentation: a comparative study. Dermatol Surg 35:59-65
Tosti A, De Padova MP, lorizzo M (2006) Types of chimica peels: advantages/disadvantages. In: Tosti A, Grimes PE, De Padova MP (eds) Color atlas of chemical peels. Springer, Berlin, pp 3-10
Furukawa F, Yamamoto Y (2006) Recent advances in chemical peeling in Japan. J Dermatol 33:655-661
Tedeschi A, Massimino D, Fabbrocini G, West EL, De Padova MP, Micali G. Chemical peeling. In: Scuderi N, Toth В (eds) International textbook of aesthetic surgery, Verduci Editore, Roma (in press)
Coleman WP III, Brody HJ (1997) Advances in chemical peeling. Dermatol Clin 15:19-26
Monheit GD (2001) Chemical peels. Curr Probl Dermatol 13:65-79
Clark E, Scerri L (2008) Superficial and medium-depth chemical peels. Clin Dermatol 26:209-218
Bernstein EF (2002) Chemical peels. Semin Cutan Med Surg 21:27-45
Landau M (2008) Chemical peels. Clin Dermatol 26:200-208
Khunger N, IADVL Task Force (2008) Standard guidelines of care for chemical peels. Indian J Dermatol Venereol Leprol 74:5-12
Zakopoulou N, Kontochristopoulos G (2006) Superficial chemical peels. J Cosmet Dermatol 5:246-253
Lawrence N, Cox SE, Brody HJ (1997) Treatment of melasma with Jessner’s solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood’s light examination. J Am Acad Dermatol 36:589-593
Stuzin JM (1998) Phenol peeling and the history of phenol peeling. Clin Plast Surg 25:1-19
Monti M (1995) Il peeling chimico. In: Caputo R, Monti M (eds) Manuale di dermocos-metologia medica. Raffaello Cortina Editore, Milano, pp 919-945
Ghersetich I, Teofoli P, Gantcheva M. Ribuffo M, Puddu P (1997) Chemical peeling: how, when, why? J Eur Acad Dermatol Venereol 8:1-11
Park JH, Choi YD, Kim SW, Kim YC, Park SW (2007) Effectiveness of modifi ed phenol peel (Exoderm) on facial wrinkles, acne scars and other skin problems of Asian patients. J Dermatol 34:17-24
В ходе подготовки статей по дерматологии для пользователей сайта МедУнивер - отечественная литература не использовалась.
